EDITOR: | January 9th, 2017

InvestorIntel Interviews Dr. Zerbe of IntelGenx on Cialis deal

| January 09, 2017 | No Comments
image_pdfimage_print

In this InvestorIntel interview, Dr. Horst G. Zerbe, President and CEO of IntelGenx Technologies Corp. (TSXV: IGX |OTCQX: IGXT), discusses the recent deal with Eli Lilly to manufacture Tadalafil (also known as Cialis®) as a pharmaceutical oral film, using IntelGenx’s VersaFilm™ technology. IntelGenx’s tadalafil oral film offers an improved discrete dosage form that does not require water intake. Dr. Zerbe states that this deal is significant because moving forward potential partner licensees will not face any litigation after completing a deal with IntelGenx, making the launch and commercialization of a VersaFilm™  partnered product extremely easy…to access the complete interview, click here

Disclaimer: IntelGenx Technologies Corp. is an advertorial member of InvestorIntel Corp.

 


Kelly Bird

Editor:

Kelly Bird joined the InvestorIntel Corp. team as the Relationship Manager in 2016, and was quickly promoted to Creative Director. An interviewer, producer and video ... <Read more about Kelly Bird>


Copyright © 2016 InvestorIntel Corp. All rights reserved. More & Disclaimer »


Leave a Reply

Your email address will not be published. Required fields are marked *